L. Jing Marantz's most recent trade in Arcturus Therapeutics Holdings Inc was a trade of 15,000 Stock option (right to buy) done . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcturus Therapeutics Hold... | Jing L. Marantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 45,715 | 45,715 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 34,285 | 101,485 (0%) | 0% | 0 | Common Stock | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 44.20 per share. | 16 Jan 2025 | 5,655 | 67,200 (0%) | 0% | 44.2 | 249,935 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 6,375 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.59 per share. | 22 Nov 2024 | 6,375 | 79,230 (0%) | 0% | 8.6 | 54,761 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.93 per share. | 22 Nov 2024 | 3,075 | 73,055 (0%) | 0% | 39.9 | 122,780 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.59 per share. | 22 Nov 2024 | 2,145 | 75,000 (0%) | 0% | 8.6 | 18,426 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 2,145 | 136,375 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.01 per share. | 22 Nov 2024 | 2,145 | 72,855 (0%) | 0% | 30.0 | 64,372 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.25 per share. | 22 Nov 2024 | 2,100 | 76,130 (0%) | 0% | 39.3 | 82,434 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.04 per share. | 22 Nov 2024 | 1,000 | 78,230 (0%) | 0% | 38.0 | 38,041 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.72 per share. | 22 Nov 2024 | 200 | 72,855 (0%) | 0% | 40.7 | 8,144 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.59 per share. | 11 Nov 2024 | 2,105 | 74,960 (0%) | 0% | 8.6 | 18,082 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 2,105 | 138,520 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 11 Nov 2024 | 2,105 | 72,855 (0%) | 0% | 30.0 | 63,158 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.59 per share. | 07 Oct 2024 | 109,375 | 182,230 (0%) | 0% | 8.6 | 939,531 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 109,375 | 140,625 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.59 per share. | 07 Oct 2024 | 67,448 | 114,782 (0%) | 0% | 25.6 | 1,725,893 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.06 per share. | 07 Oct 2024 | 39,375 | 72,855 (0%) | 0% | 30.1 | 1,183,652 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.22 per share. | 07 Oct 2024 | 2,552 | 112,230 (0%) | 0% | 26.2 | 66,923 | Common Stock |
| Arcturus Therapeutics Hold... | Jing L. Marantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Hold... | Jing L. Marantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,131 | 3,131 (0%) | 0% | 0 | Common Stock | |
| Arcturus Therapeutics Hold... | Jing L. Marantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,131 | 0 | - | - | Deferred Stock Units | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 97,145 | 97,145 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | L. Jing Marantz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 72,855 | 72,855 (0%) | 0% | 0 | Common Stock | |
| Arcturus Therapeutics Hold... | Jing L. Marantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 11,869 | 11,869 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Hold... | Jing L. Marantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 3,131 | 3,131 | - | - | Deferred Stock Units | |
| Scholar Rock Holding Corp | Jing L. Marantz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 250,000 | 250,000 | - | - | Stock Option (right to buy) |